In analysis of FASN expression with clinicopathological variables including gender, age, tumor size, lymph node and cancer stage in NPC patients, we found that higher levels of FASN expression (score of ≥3) significantly correlated with advanced primary tumor (T3–T4; p = 0.012) and distant lymph node metastasis (N1–N3; p = 0.005) of NPC (supplementary material, Table S1). The gene discussed is FASN; the disease is cancer.